Publications in collaboration with researchers from Hospital Virgen de la Arrixaca (387)

2025

  1. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

    Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 416-424

  2. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes

    Environmental Toxicology and Pharmacology, Vol. 114

  3. Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

    Expert review of cardiovascular therapy, Vol. 23, Núm. 1-2, pp. 45-51

  4. Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial

    Heart

  5. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 319-326

  6. Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine

    Revista Espanola de Cardiologia

  7. Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry

    Journal of the American Heart Association, Vol. 14, Núm. 1, pp. e030499

  8. Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

    Journal of Nutrition, Health and Aging, Vol. 29, Núm. 1

  9. Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism

    Thrombosis and Haemostasis

  10. The European Society of Cardiology quality indicators in atrial fibrillation in centers of excellence in Spain: the SEC-EXCELENTE FA registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 389-400

  11. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

    Clinical cardiology, Vol. 48, Núm. 2, pp. e70102

  12. What is the impact of dynamic score reassessment for stroke and bleeding risk outcome prediction in atrial fibrillation patients?

    Expert Review of Cardiovascular Therapy

2024

  1. Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation

    Expert Review of Neurotherapeutics, Vol. 24, Núm. 9, pp. 913-928

  2. Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial

    Circulation, Vol. 149, Núm. 25, pp. 1938-1948

  3. Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study

    Journal of Geriatric Cardiology, Vol. 21, Núm. 7, pp. 723-732

  4. Dynamic assessment of CHA2DS2-VASc and HAS-BLED scores for predicting ischemic stroke and major bleeding in atrial fibrillation patients

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 835-842

  5. Elevated Troponins after COVID-19 Hospitalization and Long-Term COVID-19 Symptoms: Incidence, Prognosis, and Clinical Outcomes—Results from a Multi-Center International Prospective Registry (HOPE-2)

    Journal of Clinical Medicine, Vol. 13, Núm. 9

  6. Impact of prior oral anticoagulation therapies on post-discharge outcomes after COVID-19: Results from a global federated health network analysis

    European Journal of Clinical Investigation, Vol. 54, Núm. 12

  7. Incidence and clinical impact of inappropriate periprocedural and perioperative management of antiplatelet therapy

    Medicina Clinica, Vol. 163, Núm. 7, pp. 336-343

  8. Invasive Treatment Strategy in Adults With Frailty and Non-ST-Segment Elevation Myocardial Infarction: A Secondary Analysis of a Randomized Clinical Trial

    JAMA network open, Vol. 7, Núm. 3, pp. e240809